Theresa Heggie sold $505k of BCRX
director at BIOCRYST PHARMACEUTICALS INC. 49,933 shares at an average of $10.11, traded Mar 20, 2026, filed Mar 24, 2026.
Score components
- +15RoleDirector
- +18Trade size$505k at market
- +10Share of holdings soldSold 43% of holdings
- +8Cluster2 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -9.3%, 3m -3.6%, 6m -9.1%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000882796-26-000017, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 20, 2026 | MOption exercise Common Stock | +49,933 | $6.30 | $315k | 115,285 | Mar 24, 2026 |
| Mar 20, 2026 | SOpen-market sale Common Stock | -49,933 | $10.11 | $505k | 65,352 | Mar 24, 2026 |
| Mar 20, 2026 | MOption exercise Automatic Stock Option Grantderivative | -49,933 | $0.00 | $0 | 0 | Mar 24, 2026 |
Related signals
Other insiders at BIOCRYST PHARMACEUTICALS INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 43Moderate | BIOCRYST PHARMACEUTICALS INC | Amy E McKee director | $100k 11,180 shares | -26% | |
| 12Weak | BIOCRYST PHARMACEUTICALS INC | Alane P Barnes Chief Legal Officer | $596k 62,500 shares | -13% | |
| 23Weak | BIOCRYST PHARMACEUTICALS INC | Alane P Barnes Chief Legal Officer | $1.4M 150,000 shares | -27% | |
| 6Weak | BIOCRYST PHARMACEUTICALS INC | Alane P Barnes Chief Legal Officer | $167k 21,773 shares | -5% | |
| 6Weak | BIOCRYST PHARMACEUTICALS INC | Alane P Barnes Chief Legal Officer | $162k 21,210 shares | -6% | |
| 15Weak | BIOCRYST PHARMACEUTICALS INC | Alane P Barnes Chief Legal Officer | $1.2M 161,680 shares | -32% | |
| 8Weak | BIOCRYST PHARMACEUTICALS INC | Machelle Sanders director | $69k 9,600 shares | -24% | |
| 39Weak | BCRXsell BIOCRYST PHARMACEUTICALS INC | Theresa Heggie director | $596k 70,000 shares | -52% | |
| 2Weak | BIOCRYST PHARMACEUTICALS INC | Nancy J Hutson director | $53k 7,000 shares | -7% | |
| 42Moderate | BIOCRYST PHARMACEUTICALS INC | Amy E McKee director | $54k 8,600 shares | -24% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.